Stocks / NASDAQ / Ardelyx, Inc.

Ardelyx, Inc.

Our Opinion

Ardelyx, Inc. is on the Cruelty Free Investing use of animals list because they exploit animals for product testing.

Additional resources:

Ardelyx’s Tenapanor Reduces Phosphorus Absorption and Protects against Vascular Calcification in Preclinical In Vivo Model of Chronic Kidney Disease.

Company Description

Ardelyx, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of minimally systemic therapeutic drugs that work in the gastrointestinal (GI) tract to treat GI and cardio-renal diseases.